首页> 外文OA文献 >Development and validation of an analytical method by hplc-dad for quantification of warfarin sodium in an extemporaneous preparation
【2h】

Development and validation of an analytical method by hplc-dad for quantification of warfarin sodium in an extemporaneous preparation

机译:hplc-dad开发和验证分析方法,用于临时制剂中华法林钠的定量分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this work was carried out the development and quantification of an analytical methodology for quantification of Warfarin Sodium in an extemporaneous suspension for hospital use. Evaluation of specificity was achieved against its excipients and degradation compounds. The selectivity was evaluated against the excipients and degradation compounds. Linearity studies were performed in a range of concentration between 0.05 to 0.15 mg/mL. Precision was evaluated in levels of repeatability and intermediate precision and accuracy in three concentration levels corresponding to the 75, 100 and 125%. The results show that the validation of the methodology is selective, linear, accurate and precise; therefore, it is reliable for use in the quantification of active warfarin sodium in the extemporaneous suspension.
机译:在这项工作中,进行了定量分析方法的开发和定量,用于医院临时悬浮液中的华法林钠定量。针对其赋形剂和降解化合物进行了特异性评估。针对赋形剂和降解化合物评估了选择性。线性研究的浓度范围为0.05至0.15 mg / mL。以重复性水平,中间精度水平和相应于75%,100%和125%的三个浓度水平的准确性来评估精度。结果表明,该方法的有效性是选择性的,线性的,准确的和精确的。因此,它可用于定量临时悬浮液中的活性华法林钠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号